News | November 13, 2023
Marksans Pharma posts Q2 FY24 consolidated PAT at Rs. 82.7 Cr
US business grew by +12.8% YoY
US business grew by +12.8% YoY
Q2FY24 EBITDA up by 105% y-o-y at Rs. 28 crore
We are redesigning Bayer to focus only on what’s essential for our mission, ‘Health for all, hunger for none’”
Total transaction value of the divestment is Rs. 3,660 million
PhytoSquene now available for clinical and commercial use
The agreement demonstrates a shared commitment to advance precision medicine and improve patient outcomes in the region
Revenue in the three months ended on Oct. 1 also slipped by 42% to US$ 13.23 billion
The drug will be marketed by Sun Pharma under the brand name RYTSTAT
The European Commission approved the use of Carbopol as an additive for liquid and solid food supplements in the EU
The companies plan to start a pivotal Phase 3 trial in the coming months
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
